HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Mäurer Selected Research

bis(beta-carboxyethyl)tin dichloride

3/2021Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer.
1/2021Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Mäurer Research Topics

Disease

4Neoplasms (Cancer)
02/2022 - 01/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 01/2018
2Breast Neoplasms (Breast Cancer)
03/2021 - 01/2021
1Frailty
02/2022
1Infections
10/2021
1Progressive Multifocal Leukoencephalopathy
10/2021
1Multiple Sclerosis
10/2021
1Inflammation (Inflammations)
10/2021
1Neoplasm Metastasis (Metastasis)
01/2021

Drug/Important Bio-Agent (IBA)

2bis(beta-carboxyethyl)tin dichlorideIBA
03/2021 - 01/2021
1Rituximab (Mabthera)FDA Link
10/2021
1Natalizumab (Tysabri)FDA Link
10/2021
1Proteins (Proteins, Gene)FDA Link
10/2021
1Hormones (Hormone)IBA
03/2021

Therapy/Procedure

3Radiotherapy
02/2022 - 01/2018
2Adjuvant Radiotherapy
03/2021 - 01/2021
1Drug Therapy (Chemotherapy)
02/2022
1Therapeutics
02/2022